IGMS (IGM Biosciences, Inc.) Forvard P/E multiplikatori

IGM Biosciences Inc. (IGMS) kompaniyasining korporativ logotipi

IgM antitanalari patentlari va FDA ning qat'iy nazorati tufayli kirishning yuqori to'siqlari IGM Biosciences, Inc. (IGMS) kompaniyasini saratonga qarshi kurashda ilmiy elita sifatida mustahkamladi. Joriy parametr 0.00 bo'lgan ushbu GURU.Markets platformasi grafigidagi kompaniyaning kelajakdagi P/E baholanishi bozor kutganlarini aks ettiradi. Xarajatlarni optimallashtirish va autoimmun patologiyalarga strategik e'tibor biznesning moliyaviy barqarorligini ta'minlaydi.

Prognoz qilingan narxning foydaga nisbati: igmbio.com (IGMS) 04.07.2022 - 24.08.2025 uchun

IGM Biosciences, Inc. kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahliliyoti:IGM Biosciences
IGM Biosciences, Inc. tovar namunasi

Yuqori sifatli portfelni shakllantirish uchun men ushbu ko'rsatkichdan bozor kutganlarini baholash vositasi sifatida foydalanaman, bunda joriy aksiya narxi kelajakdagi davrning kutilayotgan foydasiga bo'linadi. IgM antitanachalarini ishlab chiqish uchun kapital sarflayotgan tadqiqot va ishlanmalar kompaniyasi IGM Biosciences, Inc. (IGMS) uchun prognoz qilingan P/E baholash xarajatlardan patent monetizatsiyasiga o'tishni kuzatish imkonini beradi va aktivning haddan tashqari qizigan yoki past baholanganini bildiradi.

IGM Biosciences, Inc. (IGMS) raqobatchilari

Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Dianthus Pharma (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|ABCL - Forvard P/E multiplikatori|Tourmaline (TRML) - Kelajakdagi narxning foydaga nisbati|Precigen - Kelajakdagi narx-foyda multiplikatori|PHAR (Pharming Group NV) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nektar Therapeutics|Kelajakdagi narxning foydaga nisbati Upstream Bio Inc (UPB)|Forvard P/E multiplikatori zenasbio.com (ZBIO)|Kelajakdagi narxning foydaga nisbati Immunome Corp IMNM|Forvard P/E multiplikatori Gossamer Bio Inc GOSS|KALV - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prognoz qilingan narxning foydaga nisbati|Savara Inc. - Kelajakdagi narx-foyda multiplikatori|RIGL (Rigel Pharmaceuticals, Inc.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati ANAB|Forvard P/E multiplikatori ATXS|ENGN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RAPT (rapt.com)|Kapitalizatsiyaning kelajakdagi foydaga nisbati JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Kyverna Therapeutics Inc.|TLSA: Forvard P/E multiplikatori|CABA - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|VTYX (ventyxbio.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Theratechnologies Inc. THTX|Prognoz qilingan narxning foydaga nisbati AVTX (avalotx.com)|Prognoz qilingan narxning foydaga nisbati Eledon Pharmaceuticals, Inc. ELDN|Kelajakdagi narxning foydaga nisbati Agenus, Inc AGEN|Climb Bio Inc - Kelajakdagi narxning foydaga nisbati|Zura Bio Limited - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati IMA (ImageneBio)|Prognoz qilingan narxning foydaga nisbati STTK|EQ: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Connect Pharma (CNTB)|Forvard P/E multiplikatori Immunic Therapeutics (IMUX)|Forvard P/E multiplikatori ATRA (Atara Biotherapeutics)|Kelajakdagi narx-foyda multiplikatori IFRX|XFOR (X4 Pharma) - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narx-foyda multiplikatori ACET (adicetbio.com)|CELU: Forvard P/E multiplikatori|inmunebio.com (INMB) - Forvard P/E multiplikatori|BRNS (Barinthus Biotherapeutics PLC) - Forvard P/E multiplikatori|KZR: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Prognoz qilingan narxning foydaga nisbati|geovax.com - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori EDSA (Edesa Biotech Inc)|IBIO: Forvard P/E multiplikatori|Carisma Tx (CARM) - Forvard P/E multiplikatori|XTLB (XTL Biopharmaceuticals) - Forvard P/E multiplikatori|BOLT: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati HCWB (HCW Biologics, Inc.)|Forvard P/E multiplikatori Aptevo (APVO)|Forvard P/E multiplikatori AIM (aimimmuno.com)|Forvard P/E multiplikatori Aditxt Corp ADTX|GRI: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Kelajakdagi narxning foydaga nisbati|Revelation Bio (REVB) - Forvard P/E multiplikatori|INDP (Indaptus Corp) - Forvard P/E multiplikatori|SCNI: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori CALI|Prognoz qilingan narxning foydaga nisbati Affimed N.V. AFMD|Kelajakdagi narxning foydaga nisbati Allakos ALLK|HOOK: Narxning kelajakdagi foydaga nisbati|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori